Evidence map›Paper›PMID 29936583›Full record

ArticleIntensive care medicine2018

Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection.

Daniel E Freedberg, Margaret J Zhou, Margot E Cohen, Medini K Annavajhala, Sabrina Khan, Dagmara I Moscoso, Christian Brooks, Susan Whittier, David H Chong, Anne-Catrin Uhlemann and 1 more

Abstract read
In one paragraph

Article in Intensive care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Can We Identify Severe Dysbiosis at the Bedside?Critical care explorations · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Daniel E FreedbergDivision of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA. def2004@cumc.columbia.edu.
Margaret J ZhouDepartment of Medicine, Columbia University Medical Center, New York, USA.
Margot E CohenDepartment of Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA.
Medini K AnnavajhalaMicrobiome and Pathogen Genomics Core, Department of Medicine, Columbia University Medical Center, New York, USA.
Sabrina KhanMicrobiome and Pathogen Genomics Core, Department of Medicine, Columbia University Medical Center, New York, USA.
Dagmara I MoscosoDivision of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA.
Christian BrooksDivision of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA.
Susan WhittierDivision of Laboratory Medicine, Department of Pathology and Cell Biology, Columbia University Medical Center, New York, USA.
David H ChongDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Medical Center, New York, USA.
Anne-Catrin UhlemannMicrobiome and Pathogen Genomics Core, Department of Medicine, Columbia University Medical Center, New York, USA.
Julian A AbramsDivision of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, 630 West 168th Street, New York, NY, 10032, USA.

Funding

Carbapenem-resistant bacterial colonization and infection after liver transplantR01AI116939 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI UHLEMANN, ANNE-CATRIN · 2015 to 2019
$2.4M
Loss of Gastrointestinal Colonization Resistance and Antibiotic-Resistant Infections in the Intensive Care UnitK23DK111847 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FREEDBERG, DANIEL E. · 2017 to 2020
$608k
American Gastroenterological Association Research Scholar AwardNational Institute of Diabetes and Digestive and Kidney Diseases DK111847NIAID NIH HHS R01 AI116939NIDDK NIH HHS K23 DK111847
6 · The paper itself

Abstract

purposeLoss of colonization resistance within the gastrointestinal microbiome facilitates the expansion of pathogens and has been associated with death and infection in select populations. We tested whether gut microbiome features at the time of intensive care unit (ICU) admission predict death or infection.

methodsThis was a prospective cohort study of medical ICU adults. Rectal surveillance swabs were performed at admission, selectively cultured for vancomycin-resistant Enterococcus (VRE), and assessed using 16S rRNA gene sequencing. Patients were followed for 30 days for death or culture-proven bacterial infection.

resultsOf 301 patients, 123 (41%) developed culture-proven infections and 76 (25%) died. Fecal biodiversity (Shannon index) did not differ based on death or infection (p = 0.49). The presence of specific pathogens at ICU admission was associated with subsequent infection with the same organism for Escherichia coli, Pseudomonas spp., Klebsiella spp., and Clostridium difficile, and VRE at admission was associated with subsequent Enterococcus infection. In a multivariable model adjusting for severity of illness, VRE colonization and Enterococcus domination (≥ 30% 16S reads) were both associated with death or all-cause infection (aHR 1.46, 95% CI 1.06-2.00 and aHR 1.47, 95% CI 1.00-2.19, respectively); among patients without VRE colonization, Enterococcus domination was associated with excess risk of death or infection (aHR 2.13, 95% CI 1.06-4.29).

conclusionsEnterococcus status at ICU admission was associated with risk for death or all-cause infection, and rectal carriage of common ICU pathogens predicted specific infections. The gastrointestinal microbiome may have a role in risk stratification and early diagnosis of ICU infections.

Indexed as

Bacterial LoadAdultAgedAged, 80 and overAnti-Bacterial AgentsCritical CareCross InfectionFemaleGastrointestinal DiseasesGastrointestinal MicrobiomeHumansMaleMiddle AgedProspective StudiesRisk FactorsAnti-Bacterial AgentsColonization resistanceCritical careMicrobiomeMortalityNosocomial infectionVancomycin-resistant Enterococcus

Identifiers

PMID29936583
PMCPMC6309661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.